Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics

Trending on Bing

To hit Canada with 35% tariff
Cause of death revealed
Wife files for divorce
Apologizes for racial slur
Repeals paid sick leave law
US recloses southern border
Bag sells for over $10M
Wants to represent himself
Faces civil rights probe
Gun makers lose appeal
Seeks $20M in damages
Announces US tour dates
Stowaway faces extradition
Team up for HBO series
Ukrainian officer shot dead
Trump admin sues California
Gets full FDA approval
Recalls Ozark Trail bottles
Court says trial wasn't fair
Recalls 850K+ vehicles
USWNT legend Heath retires
Layoffs to begin soon
SEC charges GA lending firm
Hiker dies in Grand Canyon
Trump heads to Texas
Cowen running for Congress
Former MLB manager dies
Clash during ICE raid
Yankees release LeMahieu
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Merck to Buy Verona for $10 Billion

The Wall Street Journal on MSN · 1d
Merck to Buy Verona Pharma in $10 Billion Deal
The move bolsters Merck’s lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda.
Bloomberg on MSN · 1d
Merck to Buy Verona for $10 Billion as Patent Cliff Looms
Merck & Co. agreed to buy respiratory drugmaker Verona Pharma Plc for around $10 billion as part of its ongoing search for ways to fill the Keytruda-sized hole that will emerge over the next few years.
CNBC on MSN · 1d
Merck to buy Verona for $10 billion ahead of Keytruda patent expiration
CNBC's Angelica Peebles reports on themes emerging in the pharma space.
U.S. News & World Report3mon
Merck Buys Rights to Heart Disease Drug in Latest China Deal
Under the latest deal, announced on Tuesday, Merck will get exclusive rights to develop, manufacture and sell Jiangsu Hengrui Pharmaceuticals' experimental oral heart disease drug, HRS-5346 ...
2don MSN
Merck spends $10 billion for Verona, gaining access to its COPD medication
Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an ...
1don MSN
Merck buys Raleigh pharma company for $10 billion, drawn by new COPD drug
Verona Pharma's flagship drug last year became the first new maintenance treatment for chronic obstructive pulmonary disease ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy